Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections

Bidragets oversatte titel: Bacitracin og/eller daptomycin kombineret med cannabidiol til behandling af bakterielle infektioner

Publikation: Patent

Abstrakt

The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.
OriginalsprogEngelsk
IPCA61K 31/352,A61K 45/06,A61K 38/12,A61P 31/04
PatentnummerWO 2108/234301 A1
Journaliseringsdato27/12/2018
LandDanmark
Prioritetsdato19/06/2017
PrioritetsnummerEP20170176612
StatusUdgivet - 27. dec. 2018

    Fingerprint

Citationsformater

Klitgaard, J. K., & Wassmann, C. S. (2018). IPC nr. A61K 31/352, A61K 45/06, A61K 38/12, A61P 31/04. Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections. (Patentnummer WO 2108/234301 A1).